Cargando…

Colorectal screening among average risk individuals in the United States, 2015–2018

Colorectal cancer screening rates are important metrics for public health and quality indicators for health care systems; however, published estimates of colorectal cancer screening rates often include both high-risk and average-risk patients, and the use of different epidemiologic methods makes bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Engel-Nitz, Nicole M., Miller-Wilson, Lesley-Ann, Le, Lisa, Limburg, Paul, Fisher, Deborah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720331/
https://www.ncbi.nlm.nih.gov/pubmed/36479238
http://dx.doi.org/10.1016/j.pmedr.2022.102082
_version_ 1784843533544325120
author Engel-Nitz, Nicole M.
Miller-Wilson, Lesley-Ann
Le, Lisa
Limburg, Paul
Fisher, Deborah A.
author_facet Engel-Nitz, Nicole M.
Miller-Wilson, Lesley-Ann
Le, Lisa
Limburg, Paul
Fisher, Deborah A.
author_sort Engel-Nitz, Nicole M.
collection PubMed
description Colorectal cancer screening rates are important metrics for public health and quality indicators for health care systems; however, published estimates of colorectal cancer screening rates often include both high-risk and average-risk patients, and the use of different epidemiologic methods makes between-study comparisons tenuous. The objective of this study was to measure the proportion of average-risk American adults who are up to date with colorectal cancer screening guidelines and examine the impact of evaluation methods on screening rate estimates. This repeated cross-sectional study used administrative claims to identify individuals aged 50–75 years between 2015 and 2018 with ≥ 1-year of continuous health plan enrollment. Sensitivity analyses to replicate prior studies in the literature included: 1) retrospective cohort study requiring ≥ 10 years of continuous enrollment to identify the most current screening rates (2018), and 2) inclusion of individuals with higher colorectal cancer risk. A total of 2,579,898; 2,948,064; 3,312,882; and 2,752,864 individuals were included in the 2015, 2016, 2017, and 2018 populations, respectively. In the cross-sectional sample, the proportion of individuals with up-to-date colorectal cancer screening was 51.8%, 51.3%, 51.0%, and 51.1% in 2015, 2016, 2017, and 2018, respectively. The inclusion of high-risk individuals increased estimates approximately 37%. Using a retrospective cohort design, 67.5% of average-risk individuals were up to date in 2018. This study demonstrated the impact of methodological differences on rate estimates. Efforts to track screening rates require transparency in measurement methods to accurately evaluate progress in improving rates.
format Online
Article
Text
id pubmed-9720331
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-97203312022-12-06 Colorectal screening among average risk individuals in the United States, 2015–2018 Engel-Nitz, Nicole M. Miller-Wilson, Lesley-Ann Le, Lisa Limburg, Paul Fisher, Deborah A. Prev Med Rep Regular Article Colorectal cancer screening rates are important metrics for public health and quality indicators for health care systems; however, published estimates of colorectal cancer screening rates often include both high-risk and average-risk patients, and the use of different epidemiologic methods makes between-study comparisons tenuous. The objective of this study was to measure the proportion of average-risk American adults who are up to date with colorectal cancer screening guidelines and examine the impact of evaluation methods on screening rate estimates. This repeated cross-sectional study used administrative claims to identify individuals aged 50–75 years between 2015 and 2018 with ≥ 1-year of continuous health plan enrollment. Sensitivity analyses to replicate prior studies in the literature included: 1) retrospective cohort study requiring ≥ 10 years of continuous enrollment to identify the most current screening rates (2018), and 2) inclusion of individuals with higher colorectal cancer risk. A total of 2,579,898; 2,948,064; 3,312,882; and 2,752,864 individuals were included in the 2015, 2016, 2017, and 2018 populations, respectively. In the cross-sectional sample, the proportion of individuals with up-to-date colorectal cancer screening was 51.8%, 51.3%, 51.0%, and 51.1% in 2015, 2016, 2017, and 2018, respectively. The inclusion of high-risk individuals increased estimates approximately 37%. Using a retrospective cohort design, 67.5% of average-risk individuals were up to date in 2018. This study demonstrated the impact of methodological differences on rate estimates. Efforts to track screening rates require transparency in measurement methods to accurately evaluate progress in improving rates. 2022-12-01 /pmc/articles/PMC9720331/ /pubmed/36479238 http://dx.doi.org/10.1016/j.pmedr.2022.102082 Text en © 2022 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Regular Article
Engel-Nitz, Nicole M.
Miller-Wilson, Lesley-Ann
Le, Lisa
Limburg, Paul
Fisher, Deborah A.
Colorectal screening among average risk individuals in the United States, 2015–2018
title Colorectal screening among average risk individuals in the United States, 2015–2018
title_full Colorectal screening among average risk individuals in the United States, 2015–2018
title_fullStr Colorectal screening among average risk individuals in the United States, 2015–2018
title_full_unstemmed Colorectal screening among average risk individuals in the United States, 2015–2018
title_short Colorectal screening among average risk individuals in the United States, 2015–2018
title_sort colorectal screening among average risk individuals in the united states, 2015–2018
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720331/
https://www.ncbi.nlm.nih.gov/pubmed/36479238
http://dx.doi.org/10.1016/j.pmedr.2022.102082
work_keys_str_mv AT engelnitznicolem colorectalscreeningamongaverageriskindividualsintheunitedstates20152018
AT millerwilsonlesleyann colorectalscreeningamongaverageriskindividualsintheunitedstates20152018
AT lelisa colorectalscreeningamongaverageriskindividualsintheunitedstates20152018
AT limburgpaul colorectalscreeningamongaverageriskindividualsintheunitedstates20152018
AT fisherdeboraha colorectalscreeningamongaverageriskindividualsintheunitedstates20152018